J
J. Christopher Love
Researcher at Massachusetts Institute of Technology
Publications - 215
Citations - 20681
J. Christopher Love is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Antigen & Antibody. The author has an hindex of 55, co-authored 186 publications receiving 17873 citations. Previous affiliations of J. Christopher Love include University of Illinois at Urbana–Champaign & Harvard University.
Papers
More filters
Journal ArticleDOI
Profiling human antibody responses by integrated single-cell analysis.
Adebola O. Ogunniyi,Brittany A. Thomas,Timothy J. Politano,Navin Varadarajan,Elise Landais,Pascal Poignard,Bruce D. Walker,Douglas S. Kwon,J. Christopher Love,J. Christopher Love +9 more
TL;DR: An integrated analytical platform, using arrays of subnanoliter wells (nanowells), for constructing detailed profiles for human B cells comprising the immunophenotypes of these cells, the distribution of isotypes of the secreted antibodies, the specificity and relative affinity for defined antigens, and for a subset of Cells, the genes encoding the heavy and light chains.
Journal ArticleDOI
Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms.
Catherine Bartlett Matthews,Chapman Wright,Angel Kuo,Noelle Colant,Matthew Westoby,J. Christopher Love +5 more
TL;DR: The current understanding of a wide range of species is laid out and based on theoretical considerations which are best poised to deliver a step change in cost of manufacturing and volumetric productivity within the next decade are evaluated.
Journal ArticleDOI
Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
Brittany A. Goods,Amanda L. Hernandez,Daniel E. Lowther,Liliana E. Lucca,Benjamin A. Lerner,Murat Gunel,Khadir Raddassi,Vlad Coric,David A. Hafler,David A. Hafler,J. Christopher Love,J. Christopher Love +11 more
TL;DR: PD-1 expression on CD4 cells identifies a dysfunctional subset refractory to rescue with PD-1 blocking antibodies, suggesting that the influence of immune checkpoint inhibitors may involve recovery of function in the PD—CD4+ T cell compartment.
Journal ArticleDOI
On-chip activation and subsequent detection of individual antigen-specific T cells.
Qing Song,Qing Han,Elizabeth M. Bradshaw,Sally C. Kent,Khadir Raddassi,Björn Nilsson,Gerald T. Nepom,David A. Hafler,J. Christopher Love +8 more
TL;DR: In this article, an alternative approach that uses arrays of subnanoliter wells coated with recombinant peptide-loaded major histocompatibility complex (MHC) class II monomers to isolate and stimulate individual CD4+ T cells in an antigen-specific manner was described.
On-Chip Activation and Subsequent Detection of Individual Antigen-Specific T Cells
Qing Song,Qing Han,Elizabeth M. Bradshaw,Sally C. Kent,Khadir Raddassi,Björn Nilsson,Gerald T. Nepom,David A. Hafler,J. Christopher Love +8 more
TL;DR: This work describes an alternative approach that uses arrays of subnanoliter wells coated with recombinant peptide-loaded MHC class II monomers to isolate and stimulate individual CD4+ T cells in an antigen-specific manner, and should enable direct enumeration of antigen- Specific T cells ex vivo from clinical samples.